CTTH
CTT PHARMACEUTICAL HOLDINGS, INC.Company Information
- Company Name
- CTT PHARMACEUTICAL HOLDINGS, INC.
- CIK
- CIK0001035422
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- CTTH: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CTTH
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-28
- Last sale
- —
- Shares purchased (TTM)
- 355,500
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-09-17
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|
Assets Current | |||||||
| Assets Current | 0 | ||||||
| Assets | 0 | ||||||
Liabilities Current | |||||||
| Common Stock Value | 0 | ||||||
| Additional Paid In Capital | 8 | ||||||
Stockholders Equity | |||||||
| Stockholders Equity | 0 | ||||||
| Retained Earnings Accumulated Deficit | -8 | ||||||
| Liabilities And Stockholders Equity | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | ||||||
| Common Stock Shares Issued | 60 | ||||||
| Shares Outstanding | 60 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) — SEC Financial Statements & Analysis
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) is a pharmaceutical preparations company, incorporated in FL. CTT PHARMACEUTICAL HOLDINGS, INC. trades on OTC as: CTTH. CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-09-17. Based on that filing, CTT PHARMACEUTICAL HOLDINGS, INC. carries a market cap of $4.43M, a P/E ratio of -3.88x, a P/B ratio of 170.04x, an enterprise value of $4.43M, and an EV/EBITDA multiple of -3.88x. On profitability, it posts a Return on Equity (ROE) of -150.31%, a Return on Assets (ROA) of -131.99%, and a Return on Invested Capital (ROIC) of -158.80%. Per share, it reports EPS of $-0.02, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 69.83% year-over-year and EPS growth of -43.89% year-over-year. On the balance sheet, it maintains free cash flow of $-110.47K (TTM) and net debt of $0. Figures sourced from SEC EDGAR.
- Market Cap
- $4.43M
- P/E TTM
- -3.88x
- EPS TTM
- $-0.02
- P/B TTM
- 170.04x
- ROE TTM
- -150.31%
- ROA TTM
- -131.99%
- Free Cash Flow TTM
- $-110.47K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CTT PHARMACEUTICAL HOLDINGS, INC. in?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) operates in the Pharmaceutical Preparations industry.
What exchange does CTTH trade on?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) trades on the OTC.
Where is CTT PHARMACEUTICAL HOLDINGS, INC. incorporated?
CTT PHARMACEUTICAL HOLDINGS, INC. is incorporated in FL.
When was CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)'s most recent SEC filing?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-09-17.
What is CTTH's market cap?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) has a market capitalization of $4.43M as of 2026-06-30.
What is CTTH's EPS (earnings per share)?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)'s trailing twelve month EPS is $-0.02 as of 2026-06-30.
What is CTTH's ROE (return on equity)?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)'s trailing twelve month Return on Equity (ROE) is -150.31% as of 2026-06-30.
What is CTTH's ROA (return on assets)?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)'s trailing twelve month Return on Assets (ROA) is -131.99% as of 2026-06-30.
What is CTTH's ROIC (return on invested capital)?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)'s trailing twelve month Return on Invested Capital (ROIC) is -158.80% as of 2026-06-30.
What is CTTH's EV/EBITDA?
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)'s trailing twelve month EV/EBITDA is -3.88x as of 2026-06-30.